TrialJCO precision oncology2023

Plasma and Urine Free Glycosaminoglycans as Monitoring and Predictive Biomarkers in Metastatic Renal Cell Carcinoma: A Prospective Cohort Study.

Francesco Gatto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.